Incyte and Genesis Therapeutics Forge Strategic Collaboration to Accelerate Small Molecule Drug Discovery Using AI

Incyte  and Genesis Therapeutics, Inc. announced  that the companies have entered into a strategic collaboration focused on the researc...

February 21, 2025 | Friday | News
Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans

Artificial intelligence is reshaping oncology, and ImpriMed is at the forefront of this transformation. With its AI-powered Personalized Prediction Profi...

February 18, 2025 | Tuesday | Interview
Aveva Drug Delivery Systems Launches Generic Fentanyl Transdermal Patch in the US Market

Aveva Drug Delivery systems (A DifGen company), a leader in transdermal drug delivery systems based out of Miramar - Florida is proud t...

February 18, 2025 | Tuesday | News
Kessler Foundation Achieves Breakthrough in Spinal Cord Injury Treatment with First Epidural Spinal Stimulator Implant

The Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation is proud to announce the implantation of a spinal cord epidural stim...

February 12, 2025 | Wednesday | News
Thailand FDA Approves NERLYNX® to Reduce Breast Cancer Recurrence and Improve Survival Outcomes

A NEW breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-free survival in women is now approved for use ...

February 12, 2025 | Wednesday | News
Intuitive BioTechnologies Expands Elemental Analysis Services in North America

Intuitive BioTechnologies LLC (IBT) is proud to announce they have added elemental analysis to their testing capabilities. IBT is now offering quantitati...

February 07, 2025 | Friday | News
Illumina’s CEO Jacob Thaysen Drives Strategic Growth as Q4 Revenue Surpasses Expectations

      Illumina, led by CEO Jacob Thaysen, delivered a Q4 revenue of $1.1 billion, reflecting a steady 1% year-over-year increase, w...

February 07, 2025 | Friday | Company results
BioMed X and Merck Reveal Critical Insights on Extrachromosomal DNA in Cancer Paving the Way for Novel Therapies

The research of BioMed X team EDC - Extrachromosomal DNA in Cancer - has uncovered critical insights into the mechanisms driving extrachromosomal ...

February 06, 2025 | Thursday | News
BD Announces Strategic Plan to Separate Biosciences and Diagnostic Solutions Business to Unlock Value for Shareholders

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced its board of directors has unanimously authoriz...

February 06, 2025 | Thursday | News
PhaseV Partners with Alimentiv to Revolutionize GI Clinical Trials Using Machine Learning

 PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced  it has entered a strategic partnership with&...

February 04, 2025 | Tuesday | News
Marc N. Casper on Thermo Fisher's Strong 2024 Finish: "We Drove Meaningful Growth, Positioned for Excellence in 2025

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year...

January 30, 2025 | Thursday | Company results
SeaBeLife Introduces SBL03: A First-of-Its-Kind Topical Treatment for Retinal Cell Necrosis in Geographic Atrophy

SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect retina fr...

January 30, 2025 | Thursday | News
CPC Launches MicroCNX® Nano Series Aseptic Connectors to Transform Cell and Gene Therapy Processing

CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutical pro...

January 30, 2025 | Thursday | News
Datar Cancer Genetics Launches AI-Powered Video Reporting Service for Chemosensitivity Testing

Datar Cancer Genetics (DCG) has launched a revolutionary video reporting service for in vitro chemosensitivity testing, powered by AI-based technology. Thi...

January 29, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close